Vivesto Stock

Vivesto EBIT per Employee

The EBIT per Employee of Vivesto (VIVE.ST) as of Aug 10, 2026 is -2.14 M SEK. In the previous year, EBIT per Employee was -5.84 M SEK — a change of -63.33% (higher).

EBIT per Employee

-2.14 MSEK

YoY

-63.33%

Last updated:

EBIT per Employee of Vivesto is 2026 -2.14 M SEK. EBIT per Employee of Vivesto was 2025 -5.84 M SEK. It decreases by -63.33% higher compared to the previous year.
Access this data via the Eulerpool API

Vivesto Stock analysis

What does Vivesto do? Oasmia Pharmaceutical AB is a Swedish pharmaceutical company that specializes in the development and marketing of innovative cancer and pain medications. The company was founded in 1998 and is headquartered in Uppsala, Sweden. Vivesto is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vivesto stock

EBIT per Employee of Vivesto is -2.14 M SEK in 2026.

EBIT per Employee of Vivesto changed from -5.84 M SEK to -2.14 M SEK, representing a -63.33% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Employee Vivesto since 2006 – with annual values, charts, and detailed analysis.

EBIT per employee measures operating profit per employee, showing how efficiently the workforce generates operating earnings.

EBIT per Employee's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT per Employee's Vivesto historically and in real time.

Access this data via the Eulerpool API

Workforce — Vivesto

All Key Metrics — Vivesto